Visually Evoked Potential as Prognostic Biomarker for Neuroaxonal Damage in Multiple Sclerosis From a Multicenter Longitudinal Cohort.
Frederike Cosima OertelJulia KrämerSeyedamirhosein MotamediAzeen KeihaniHanna G ZimmermannNikolaos G DimitriouShivany Condor MontesCharlotte BereuterChristian CordanoAhmed AbdelhakAnand TripOrhan AktasSven G MeuthHeinz WiendlKlemens RuprechtJudith Bellmann-StroblFriedemann PaulAxel PetzoldAlexander Ulrich BrandtPhilipp AlbrechtAri J GreenPublished in: Neurology(R) neuroimmunology & neuroinflammation (2023)
VEP in non-ON eyes seems to be a promising marker of demyelination in RRMS and of potential prognostic value for subsequent retinal ganglion cell loss. This study also provides evidence that VEP may be a useful and reliable biomarker for multicenter studies.